Asthator 4mg Tablet

Asthator 4mg Tablet contains Montelukast 4mg, a leukotriene receptor antagonist formulated at a lower paediatric strength for use in young children who have been diagnosed with asthma or, in some cases, allergic rhinitis. Montelukast works by blocking leukotrienes, natural chemicals in the body that contribute to airway inflammation, tightening, and mucus production, helping to reduce the frequency and severity of asthma symptoms and allergy-related breathing difficulty.

Asthator 4mg Tablet is a prescription-only medicine in Malaysia. DoctorOnCall requires an online medical consultation so a doctor can assess the child’s diagnosis, weight, and suitability before a prescription is issued and the medicine is dispensed by a registered pharmacist.

Montelukast selectively blocks the cysteinyl leukotriene receptor (CysLT1), preventing leukotrienes from triggering inflammation, swelling, and constriction of the airway muscles. By interrupting this pathway, it helps keep the airways more open and less reactive over time, making it useful as a preventive, maintenance-type treatment rather than a rescue medicine for sudden asthma attacks.

Asthator 4mg Tablet is usually given once daily in the evening, as prescribed by the child’s doctor, and can be taken with or without food. If the tablet is chewable or dispersible, follow the specific instructions given by the pharmacist on how to administer it to a young child; this medicine should be given consistently every day, even when the child feels well, unless the doctor advises otherwise.

The 4mg strength is intended for young children within the age range specified by the prescribing doctor, and the exact dose and duration should follow the doctor’s instructions precisely. It is not a fast-acting rescue treatment, so it will not relieve a sudden asthma attack, and a reliever inhaler should still be available as directed by the child’s doctor.

Asthator 4mg Tablet should be used within the shelf life printed on the packaging when stored correctly. Do not use the tablets after the expiry date, and any unused or expired medicine should be disposed of safely rather than kept for later use.

Store Asthator 4mg Tablet at room temperature, away from direct light, heat, and moisture, in its original packaging until it is time for the next dose. Keep the medicine well out of the reach of children, as this and similar chewable formulations can be mistaken for sweets.

• Known hypersensitivity to montelukast or any ingredient in the tablet
• Not intended for relief of acute asthma attacks or status asthmaticus
• Use with caution in children with a history of mental health or behavioural changes, and report any new mood or behaviour symptoms to the doctor
• Should not replace other prescribed asthma medicines without the doctor’s specific instruction
• Use only under medical guidance if the child has liver impairment

• May interact with certain enzyme-inducing medicines such as phenobarbital or rifampicin, which can reduce montelukast’s effect
• Inform the doctor of all other medicines, including other asthma or allergy treatments, the child is taking
• No significant food restrictions are required, and it can be taken with or without meals
• Do not combine with other leukotriene modifiers unless specifically directed by the doctor

• Give the dose at the same time each evening to build a consistent routine
• Continue giving this medicine daily even when the child has no symptoms, unless the doctor says to stop
• Always keep a reliever inhaler available as prescribed, since this medicine does not treat sudden attacks
• Watch for and report any unusual mood, behaviour, or sleep changes to the doctor
• Keep all scheduled follow-up appointments to monitor the child’s asthma control
• Store safely away from young children to avoid accidental ingestion

Asthator 4mg Tablet is generally used as a long-term preventive treatment and works best when given regularly as part of an overall asthma management plan agreed with the child’s doctor. Parents and caregivers should keep track of symptom frequency and any side effects, particularly changes in mood or behaviour, and discuss these at follow-up visits so that treatment can be adjusted if needed.